» Articles » PMID: 31171909

Decreased DNA Methyltransferases Expression is Associated with Coronary Artery Lesion Formation in Kawasaki Disease

Overview
Journal Int J Med Sci
Specialty General Medicine
Date 2019 Jun 8
PMID 31171909
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Kawasaki disease (KD) is the most common acute coronary vasculitis to occur in children. Although we have uncovered global DNA hypomethylation in KD, its underlying cause remains uncertain. In this study, we performed a survey of transcript levels of DNA methyltransferases and demethylases in KD patients. We recruited 145 participants for this study. The chip studies consisted of 18 KD patients that were analyzed before undergoing intravenous immunoglobulin (IVIG) treatment and at least 3 weeks after IVIG treatment, as well as 36 control subjects, using Affymetrix GeneChip® Human Transcriptome Array 2.0. An additional study of 91 subjects was performed in order to validate real-time quantitative PCR. In our microarray study, the mRNA levels of DNMT1 and DNMT3A were significantly lower while TET2 was higher in acute-stage KD patients compared to the healthy controls. Through PCR validation, we observed that the expression of DNMT1 and TET2 are consistent with the Transcriptome Array 2.0 results. Furthermore, we observed significantly lower DMNT1 mRNA levels following IVIG treatment between those who developed CAL and those who did not. Our findings provide an evidence of DNA methyltransferases and demethylases changes and are among the first report that transient DNA hypomethylation is induced during acute inflammatory phase of Kawasaki disease.

Citing Articles

Role of Folate in Liver Diseases.

Yang M, Wang D, Wang X, Mei J, Gong Q Nutrients. 2024; 16(12).

PMID: 38931227 PMC: 11206401. DOI: 10.3390/nu16121872.


Pharmacogenomics of coronary artery response to intravenous gamma globulin in kawasaki disease.

Shrestha S, Wiener H, Chowdhury S, Kajimoto H, Srinivasasainagendra V, Mamaeva O NPJ Genom Med. 2024; 9(1):34.

PMID: 38816462 PMC: 11139870. DOI: 10.1038/s41525-024-00419-7.


The Role of Clonal Hematopoiesis of Indeterminant Potential and DNA (Cytosine-5)-Methyltransferase Dysregulation in Pulmonary Arterial Hypertension and Other Cardiovascular Diseases.

Emon I, Al-Qazazi R, Rauh M, Archer S Cells. 2023; 12(21).

PMID: 37947606 PMC: 10650407. DOI: 10.3390/cells12212528.


Whole-exome sequencing analysis identifies novel variants associated with Kawasaki disease susceptibility.

Zhang X, Sun Y, Meng L, Ye C, Han H, Zhang T Pediatr Rheumatol Online J. 2023; 21(1):78.

PMID: 37550746 PMC: 10405421. DOI: 10.1186/s12969-023-00857-0.


The role of mitochondria in the pathogenesis of Kawasaki disease.

Beckley M, Shrestha S, Singh K, Portman M Front Immunol. 2022; 13:1017401.

PMID: 36300112 PMC: 9592088. DOI: 10.3389/fimmu.2022.1017401.


References
1.
Jeltsch A . Beyond Watson and Crick: DNA methylation and molecular enzymology of DNA methyltransferases. Chembiochem. 2002; 3(4):274-93. DOI: 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S. View

2.
Newburger J, Takahashi M, Gerber M, Gewitz M, Tani L, Burns J . Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart.... Circulation. 2004; 110(17):2747-71. DOI: 10.1161/01.CIR.0000145143.19711.78. View

3.
Wang C, Wu Y, Liu C, Kuo H, Yang K . Kawasaki disease: infection, immunity and genetics. Pediatr Infect Dis J. 2005; 24(11):998-1004. DOI: 10.1097/01.inf.0000183786.70519.fa. View

4.
Shilatifard A . Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu Rev Biochem. 2006; 75:243-69. DOI: 10.1146/annurev.biochem.75.103004.142422. View

5.
Wilson A, Power B, Molloy P . DNA hypomethylation and human diseases. Biochim Biophys Acta. 2006; 1775(1):138-62. DOI: 10.1016/j.bbcan.2006.08.007. View